DailyIQ
Last updated1 minute ago

XYL·Xylem Inc.

$104.57
+2.15 (+2.10%)
Pre-Market
High
$104.34
Open
$104.34
Market Cap
23.89B
52W High
$154.27
Low
$104.34
P. Close
$104.57
P/E
23.46
52W Low
$98.58
Fwd P/E
16.79
DailyIQ Est.
$157.17
Inst. Ownership
41.6%
Short Interest
4.77%
Days to Cover
3.8
Technical Score (1D)
14
BEARISH
News Sentiment
46
MIXED
On Oct 5, UBS analyst Joshua Spector lowered Xylem’s price target from $138 to $112 while keeping a neutral outlook. The revision was based on the company’s recent earnings miss and a weaker outlook for water infrastructure demand. The downgrade was reported as a modest headwind for the stock. UBS maintained a neutral stance, indicating a slight negative bias. The change was noted as potentially influencing short‑term investor sentiment and could pressure the share price.
LOW TARGET
$129 +23.4%
2 analysts
MEAN TARGET
$153 +46.3%
13 analysts
HIGH TARGET
$180 +72.1%
13 analysts
PRICE RANGE
$129.00 - $180.00
SB / B / H / S / SS
8/10/8/1/1
DAILYIQ EST.
$157.17 (+50.3%)
Sector
Industrials
Industry
Specialty Industrial Machinery
Exchange
NYQ
Country
United States
Website
Symbol
XYL
Description
Xylem Inc. is a global provider of engineered water solutions, serving diverse markets including utilities, industrial facilities, and commercial buildings. The company's core business revolves around designing, manufacturing, and servicing a wide array of products, from pumps and filtration systems to smart meters and data analytics platforms. Xylem operates through distinct segments, offering solutions for water infrastructure, applied water applications, measurement and control, and comprehensive water services. Their offerings encompass well-known brands that provide essential products and services for water and wastewater treatment, as well as critical infrastructure management. Established in 2011, Xylem is headquartered in Washington, D.C., and continues to focus on providing innovative solutions for the world's water challenges.
Bought (1Y)
0 shares
$0
Sold (1Y)
0 shares
$0
McShane Geri-MichelleSVP, CAO
Award/Grant4,225 shares2026-10-01
Johnston Joseph PatrickEVP & President, AW
Award/Grant2,298 shares2026-09-01
Johnston Joseph PatrickEVP & President, AW
Award/Grant645 shares2026-09-01
van der Berg Andrea MicheleEVP & Chief Financial Officer
Award/Grant6,034 shares2026-09-01
van der Berg Andrea MicheleEVP & Chief Financial Officer
Award/Grant1,693 shares2026-09-01
79/ 100
Bullish
Overall: Bullish
✓Revenue growing year over year
✓Positive net margin
✓Positive operating cash flow
Gross Margin
38.5%
Net Margin
10.6%
Revenue CAGR
7.5%
Current Ratio
1.62x
Debt / Equity
0.12x
Return on Equity
8.3%
Earnings Summary
Xylem Inc. is a global provider of engineered water solutions, offering pumps, filtration systems, smart meters, and data analytics across utilities, industrial, and commercial markets. The company’s diversified product portfolio supports steady demand for water infrastructure and applied water applications. In Q1 2026, Xylem reported EPS of $1.12 versus an estimate of $1.349, a 17% miss, and revenue of $2.125 billion against an estimate of $2.311 billion, a 7.8% miss; this follows Q4 2025 where EPS of $1.42 beat the $1.152 estimate and revenue of $2.397 billion beat the $2.173 billion estimate. The company has shown a mixed earnings pattern, with four consecutive quarters of EPS beats from Q4 2024 through Q3 2025, followed by a miss in Q1 2026, indicating a potential slowdown. Historically, Xylem has delivered consistent revenue growth year‑over‑year, with a 4‑quarter streak of revenue beats, while EPS has fluctuated around analyst expectations. Recent news includes a UBS downgrade that lowered the price target to $112 after an earnings miss, reflecting concerns over weaker water infrastructure demand, and a SeekingAlpha buy recommendation citing a strong dividend streak and strategic acquisitions; these developments suggest market sensitivity to earnings performance and macro‑demand trends.

EPS

EstBeatMiss
$1.07$1.18$1.29$1.40$1.51Q2'25Q3'25Q4'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$1.45 - -
Q2'26$1.46$1.46-0.1%
Q1'26$1.35$1.12-17.0%
Q4'25$1.15$1.42+23.2%
Q3'25$1.23$1.37+11.1%
Q2'25$1.15$1.26+9.9%

Revenue

EstBeatMiss
$2.1B$2.2B$2.3B$2.3B$2.4BQ2'25Q3'25Q4'25Q1'26Q2'26Q3'26
QtrEstActual+/−
Q3'26$2.3B - -
Q2'26$2.4B$2.3B-1.2%
Q1'26$2.3B$2.1B-8.1%
Q4'25$2.2B$2.4B+10.3%
Q3'25 - $2.3B -
Q2'25 - $2.3B -

Market Data

XYL Stock Snapshot

BEARISH14/100
$104.34−$0.16 (0.2%)
Market cap
23.89B
P/E ratio
23.5
Day range
$104.34 – $104.34
News sentiment
46/100 · Neutral
Analyst target
$152.94 (+46.6%)
Consensus
Buy · 28 analysts
52-week range+5.8% off low · -32.4% from high
$98.58$154.27
Price $104.34 DailyIQ Est. $157.17

The trend on XYL is bearish, and the indicator set is confirming it rather than diverging. In Industrials, names this size usually take direction from sector flows before company-level news.

Reverse DCF

What growth is priced into XYL?

RICH

At today's price, Xylem Inc. needs to grow free cash flow about 14.9% a year for the next 10 years to justify its valuation at a 8.74% cost of capital. Over its actual history it has compounded free cash flow at 6.8% a year, so the market is asking for 8.1 percentage points above its own delivered rate. On that basis XYL looks priced above what its own growth record supports.

Implied FCF growth
14.9%
Historical FCF CAGR
6.8%
Growth gap
+8.1 pts
Verdict
RICH
Discount rate (WACC)
8.74%
Beta
0.78

Behaviour On Record

What XYL's own history says about today's numbers

Realized volatility (21d)
29.8% 79th pct
Below its peak
-33.1%
vs 200-day average
-15.4%
Up days (1y)
47%

Xylem Inc. is currently running 29.8% annualised volatility over the last 21 sessions. Measured against XYL's own 13 years of daily returns rather than a market-wide average, that is the 79th percentile — elevated for this stock, against a typical reading of 22.2%. The distinction matters because a number that looks calm for one stock is turbulent for another, and the absolute figure on its own tells you neither.

XYL is trading -33.1% below its running peak. Across 12 full years on file, its median worst-drawdown-in-a-year was -20.5%, and the deepest was -38.3% in 2022. The current drawdown is already deeper than this stock's typical annual low point, which puts it in the part of its range where past recoveries began — and where past declines also continued.

Price sits -15.4% from its 200-day moving average. Against every other day in its history, that gap ranks at the 6th percentile — a narrower gap than it typically runs. Over the past year XYL closed higher on 47% of sessions, and it is currently 2 sessions into a rising streak.

On October specifically: over 13 years of records, XYL finished the month higher 9 of 13 times, with a median return of +4.3% and an average of +2.9%. Its strongest month historically has been November at +3.9% on average, its weakest March at -1.6%. Seasonality is a weak signal on its own — a decade is a small sample and regimes change — but it is a real distribution rather than a rule of thumb.

Overnight risk is measurable too: XYL has opened more than 2% away from the prior close in 117 of 3,267 sessions (3.6% of the time), with the largest gaps running +6.6% and -17.0%. For anyone holding through an event, that rate is a better guide to overnight exposure than the intraday range.

Across the last 3 dated reports on file, XYL moved an average of 2.0% in the session after earnings, closing higher 0 of those 3 times, with a median move of -1.7% and a largest of -2.8%.

All figures computed from 3,268 daily closes between 2013-10-07 and 2026-10-05, split-adjusted, recomputed daily. Percentiles are against XYL's own 13-year history, not a peer group or index.

Sector Rotation

Is money rotating into or out of XYL's sector?

Xylem Inc. sits in the Industrials sector, currently ranked 5th of 12 GICS sectors by relative-strength rotation score (improving).

Sector rank
#5 of 12
Sector state
Improving
Sector rotation score
55

Options Market

What is the options market pricing for XYL?

CallsPuts

For Xylem Inc.'s nearest expiry (2026-12-18, 72 days out), open interest is call-heavy, a bullish tilt (put/call ratio of 0.00), with at-the-money implied volatility around 3.1%. The options market is pricing roughly a ±1.4% move by that expiry — a range of about $99.53–$102.33.

Put/call ratio (2026-12-18)
0.00
ATM implied volatility
3.1%
Total open interest
5
Expected move by 2026-12-18
±1.4% ($99.53–$102.33)

Analyst Rating Changes

Are analysts turning bullish or bearish on XYL?

Jefferies most recently reiterated its rating on Xylem Inc. to Buy on Aug 24, 2026 with a price target of $150 (from $145). Over the last 90 days, coverage has run 0 upgrades against 0 downgrades, a net mixed lean.

Latest action
Jefferies — Buy
90-day upgrades
0
90-day downgrades
0
Net rating momentum
0
DateFirmActionRatingPrice target
Aug 24, 2026JefferiesMaintainedBuy$145 → $150
Aug 13, 2026UBSMaintainedNeutral$135 → $138
Jul 30, 2026UBSMaintainedNeutral$129 → $135
Jul 29, 2026StifelMaintainedBuy$157 → $160
Jul 29, 2026MizuhoMaintainedNeutral$124 → $130
Jul 29, 2026RBC CapitalMaintainedOutperform$159 → $164
Jul 29, 2026BarclaysMaintainedOverweight$154 → $159
Jul 29, 2026BairdMaintainedOutperform$163 → $165
Jul 20, 2026StifelMaintainedBuy$159 → $157
Jul 16, 2026RBC CapitalMaintainedOutperform$157 → $159
Jun 25, 2026JefferiesUpgradeHold → Buy$130 → $140
Apr 29, 2026UBSMaintainedNeutral$132 → $133

XYL Competitive Positioning

Xylem Inc. (XYL) is tracked alongside these names in Specialty Industrial Machinery on DailyIQ — ranked by market cap, with today's move alongside.

News Sentiment Analysis

Sentiment gathered from recent headlines

46/100
Strong NegativeNeutralStrong Positive
MIXED

Recent News Coverage

Most recent articles, ranked by recency (click to expand).

10+ articles
What did this article say?
UBS analyst Joshua Spector downgraded Xylem’s price target from $138 to $112 while keeping a neutral outlook. The revision reflects concerns about the company’s recent earnings miss and weaker outlook for water infrastructure demand. The downgrade signals a modest headwind for the stock, though the analyst did not issue a negative recommendation. The move is likely to influence short‑term investor sentiment and could pressure the share price.
What did this article say?
The article compares Xylem (XYL) and Zurn Water (ZWS) for value investors, noting both companies hold a Zacks Rank of #2 (Buy). It highlights that both firms have improving earnings outlooks due to positive analyst estimate revisions. The analysis emphasizes that XYL and ZWS share similar value metrics, such as strong P/E ratios and dividend yields, making them attractive for value-focused portfolios.
What did this article say?
UBS reduced its price target for Xylem (XYL) from $138 to $112 while keeping a neutral rating. The downgrade reflects a reassessment of the company’s valuation relative to peers. The move signals a modest headwind for the stock, though the rating remains unchanged. Investors may view the adjustment as a cautionary signal rather than a dramatic shift.
What did this article say?
Xylem (XYL) received a buy recommendation from SeekingAlpha on October 4, citing a 14‑year dividend growth streak, a low payout ratio, and a robust balance sheet. The company’s shares were trading 10‑18% below a conservative fair‑value estimate, underscoring perceived undervaluation. XYL’s growth is supported by steady organic demand, strategic acquisitions expected to be accretive by 2027, and margin expansion. Despite macro headwinds and a 25% year‑to‑date decline in share price, XYL maintains solid order growth, a growing backlog, and favorable long‑term demand from data centers and municipalities.
What did this article say?
Xylem reported its Q2 earnings, with revenues falling short of analyst consensus by 6.4%. The company’s guidance remained unchanged, and its share price dropped 16.5% since the earnings release. Market sentiment reflected concerns over economic sensitivity and slower industrial demand for water infrastructure solutions. The results suggest a modest headwind for the company’s short‑term performance.
What did this article say?
Xylem’s revenue grew 11.9% CAGR over five years, outpacing the industrials average, and its free cash flow margin has improved, indicating stronger financial health. The company’s stock had declined 16.4% over the past six months, but the underlying fundamentals suggest a potential rebound. Analysts view the recent pullback as a buying opportunity, citing the company’s solid performance and market positioning in the water sector.
What did this article say?
BNP Paribas reduced its price target for Xylem (XYL) from $160 to $145, citing a reassessment of the company’s valuation. The bank maintained an outperform rating and an overweight consensus among analysts. The adjustment reflects a more conservative view on Xylem’s growth prospects, though the overall recommendation remains positive. The change signals a modest headwind for the stock, potentially impacting short‑term investor sentiment.
What did this article say?
Xylem Inc. scheduled the release of its third‑quarter 2026 financial results for October 27, 2026, at 6:55 a.m. ET, followed by a senior‑management conference call at 9:00 a.m. ET. The company will provide a replay of the briefing through November 10, 2026, and investors can access the call via telephone or online. The announcement is a routine disclosure of upcoming earnings, with no immediate operational or strategic implications disclosed.
What did this article say?
Xylem Inc. continued its strong second‑quarter 2026 performance, with the Water Solutions and Services segment orders climbing 147% to $1.45 billion, largely due to an $850 million, 23‑year outsourced water contract. The Applied Water segment benefited from commercial building and data‑center demand, while the Measurement & Control Solutions segment saw smart‑metering growth offsetting electric metering delays. XYL projected year‑over‑year revenue growth of about 2% on a reported basis and 2‑3% on an organic basis, and announced the completion of the TriOS acquisition for approximately €190 million to enhance optical sensing capabilities. These results underscore XYL’s continued expansion and market strength.
What did this article say?
Xylem’s shares fell 27.2% over the past year, prompting investors to reassess whether the current price reflects the company’s projected cash flows. The firm’s focus on water infrastructure and treatment projects ties its earnings to the timing and durability of long‑term customer investment programs. Analysts noted that the 23.5x P/E ratio suggests a different valuation narrative than the market’s current discount. The article highlights the tension between a declining stock price and the underlying cash‑flow fundamentals, raising uncertainty about the stock’s true value.

Technical Analysis

Real-time indicators across multiple timeframes

14
BEARISH
Technical indicators reflect the latest computed signal mix for this timeframe.
Unlock full technicals
Create a free account to access more indicators and deeper timeframe data.
Institutional & Hedge Fund Ownership
25 tracked managers · $11.62B combined position · 10 adding, 13 trimming, 2 unchanged (latest 13F filings)
ManagerTrendShares Held% of Co.Position ValueFiled
Vanguard Group Inc▲ Buy30,054,74313.15%$4.09B2026-01-29
BlackRock, Inc.▼ Sell25,037,89610.95%$2.96B2026-08-07
Geode Capital Management, LLC▼ Sell6,347,7842.78%$747.35M2026-08-12
Invesco Ltd.▲ Buy5,102,0442.23%$603.11M2026-08-14
Morgan Stanley▲ Buy4,312,7571.89%$509.81M2026-08-13
Northern Trust Corp▼ Sell3,295,2151.44%$389.53M2026-08-13
Norges Bank▼ Sell2,544,4521.11%$300.78M2026-08-12
Goldman Sachs Group Inc▲ Buy2,352,7151.03%$278.11M2026-08-14
Artisan Partners Limited Partnership▼ Sell2,275,2141.00%$271.89M2026-05-13
Wells Fargo & Company▼ Sell1,919,6800.84%$226.93M2026-08-14
Bank of America Corp▲ Buy1,841,7340.81%$217.71M2026-08-14
AQR Capital Management LLC▲ Buy1,418,0180.62%$165.81M2026-08-14
Janus Henderson Group plc• Hold883,8780.39%$105.66M2026-05-18
Renaissance Technologies LLC▼ Sell790,4710.35%$93.44M2026-08-13
Man Group plc▲ Buy767,3830.34%$90.71M2026-08-14
JPMorgan Chase & Co▼ Sell719,8180.31%$84.02M2026-08-12
Citadel Advisors LLC• Hold705,6020.31%$83.41M2026-09-02
D. E. Shaw & Co., Inc.▼ Sell600,5850.26%$71.00M2026-08-14
Wellington Management Group LLP▼ Sell506,4330.22%$59.87M2026-08-14
Gotham Asset Management, LLC▲ Buy460,5840.20%$54.45M2026-08-14
Citigroup Inc▲ Buy440,2740.19%$52.04M2026-08-03
Susquehanna International Group, LLP▼ Sell342,8480.15%$40.53M2026-08-14
FMR LLC (Fidelity)▲ Buy337,6140.15%$39.91M2026-08-13
Millennium Management LLC▼ Sell334,2040.15%$39.51M2026-08-14
Fisher Asset Management, LLC▼ Sell330,6340.14%$39.08M2026-08-04
Q2 2026 flow:3.30M sh bought ($389.30M)1.40M sh sold ($165.21M)net +1.90M sh (+$224.08M)